Accessibility Menu
Delivra Health Brands logo

Delivra Health Brands(TSXV) DHB

Market CapCA$3.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-99%
5 Year-89%
1 Year-57%
1 Month+5%
CA$0.10
-9.09%
-0.01Today
Delivra Health Brands last closing stock price
MetricPriceDate
Last closeCAD 0.102026-08-28
Delivra Health Brands stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-16.67%CAD 0.122026-08-21
1 month+5.26%CAD 0.102026-07-29
3 month-33.33%CAD 0.152026-05-29
Year to date-51.22%CAD 0.212025-12-31
1 year-57.45%CAD 0.242025-08-28
3 year-33.33%CAD 0.152023-08-29
5 year-88.89%CAD 0.902021-08-27
Since inception-98.61%CAD 7.202017-04-28

Delivra Health Brands Financials at a Glance

Market Cap

CA$3.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$11.25M

Net Income (TTM)

-CA$1.01M

EPS (TTM)

-CA$0.03

P/E Ratio

-3.10

Dividend

CA$0.00

Beta (Volatility)

0.34 (Low)

Price

CA$0.10

Volume

762

Open

CA$0.11

Previous Close

CA$0.10

Daily Range

CA$0.10 - CA$0.11

52-Week Range

CA$0.09 - CA$0.37

Estimated Earnings Date

Oct 6, 2026

DHB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Delivra Health Brands

Delivra Health Brands Inc. is a Vancouver-based company specializing in the distribution of lifestyle and wellness products, including cannabis and sleep aids. The firm operates under well-known brands such as LivRelief and Dream Water, catering to both consumers and medical patients in regulated markets.

Products and Services
  • Cannabis products for wellness and recreational use
  • Liquid and powdered sleep supplements
  • Topical pain relief solutions and edible gummies
Growth Outlook
  • Recent quarterly revenue reached CAD 1,247,000, indicating potential for recovery
  • Strong brand recognition supports market expansion opportunities
  • Focus on innovative product development aligns with consumer trends
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 12,000,000 reflects growth potential
  • Current ratio of 3.29 indicates strong liquidity position
  • Net income for the latest quarter was CAD -1,028,000, highlighting ongoing challenges
Delivra Health Brands Inc. operates in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. The company has shown resilience in its revenue generation, with a TTM revenue of CAD 12 million, despite facing challenges reflected in its recent net income figures. The current ratio of 3.29 suggests a solid liquidity position, allowing the company to meet short-term obligations effectively. The latest quarterly results indicate a revenue of CAD 1,247,000, which may signal a potential recovery trajectory. The company’s commitment to innovation and brand development positions it well to capitalize on emerging market trends, particularly in the wellness and cannabis sectors. As consumer preferences shift towards natural and holistic health solutions, Delivra Health Brands Inc. is poised to leverage its established brand portfolio to capture market share. Investors may find the company's focus on product diversification and market expansion appealing, especially as it navigates the evolving landscape of the wellness industry.
AI Generated • Aug 12, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Gord Davey

Website

www.delivrahealthbrands.com

Headquarters

Vancouver, BC V6C 3E2, CA

DHB Financials

Key Financial Metrics (TTM)

Gross Margin

45.51%

Operating Margin

-8.52%

Net Income Margin

-8.99%

Return on Equity

-26.42%

Return on Capital

-13.24%

Return on Assets

-14.19%

Earnings Yield

-32.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$3.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

31.26M

Volume

762

Avg. Volume

16.80K

Financials (TTM)

Gross Profit

CA$5.12M

Operating Income

-CA$958.00K

EBITDA

-CA$507.00K

Operating Cash Flow

-CA$325.00K

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$325.00K

Cash & ST Invst.

CA$2.64M

Total Debt

CA$2.33M

Delivra Health Brands Performance Analysis

Delivra Health Brands annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30CAD 8,139,000N/A
20232023-06-30CAD 9,791,00020.3%
20242024-06-30CAD 12,378,00026.4%
20252025-06-30CAD 13,370,0008.0%
Delivra Health Brands sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3040.8%
Q12025-09-30-26.4%
Q22025-12-31-24.1%
Q32026-03-31-48.7%
Delivra Health Brands annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30CAD -0.28N/A
20232023-06-30CAD -0.01-97.4%
20242024-06-30CAD 0.03N/A
20252025-06-30CAD -0.04N/A
Delivra Health Brands sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30223.0%
Q12025-09-30-117.5%
Q22025-12-31-355.2%
Q32026-03-31-149.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$1.25M

-59.7%

Gross Profit

CA$311.00K

-80.0%

Gross Margin

24.94%

N/A

Market Cap

CA$3.13MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$142.10K

N/A

Employees

22

N/A

Net Income

-CA$1.03M

-143.6%

EBITDA

-CA$960.00K

-2900.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$2.64M

-24.4%

Total Debt

CA$2.33M

+4.9%

Accounts Receivable

CA$2.20M

-20.7%

Inventory

CA$2.17M

+21.6%

Long Term Debt

CA$2.02M

+1.7%

Short Term Debt

CA$317.00K

+31.0%

Return on Assets

-14.19%

N/A

Return on Invested Capital

-19.32%

N/A

Free Cash Flow

-CA$844.00K

-34.0%

Operating Cash Flow

-CA$844.00K

-34.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CTX.TOCrescita Therapeutics Inc.
CA$0.79+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About DHB

What is the current price of Delivra Health Brands?

Delivra Health Brands is trading at CA$0.10 per share.

What is the 52-week range for Delivra Health Brands?

Over the past 52 weeks, Delivra Health Brands has traded between CA$0.09 and CA$0.37.

How much debt does Delivra Health Brands have?

As of the most recent reporting period, Delivra Health Brands reported total debt of CA$2.33M.

How much cash does Delivra Health Brands have on hand?

Delivra Health Brands reported CA$2.64M in cash and cash equivalents in its most recent financial results.

What is Delivra Health Brands’s dividend yield?

Delivra Health Brands does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services